Fundraising FoxForepont Capital Partners — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
GPN Vaccinesgpnvaccines.comJun 2024 · $18M
GPN Vaccines is a clinical-stage company developing vaccines against bacterial pathogens, including a vaccine to prevent pneumococcal disease.
BiotechHealthtechNew York, US
Timothy Hirst(Executive Officer, Director)James Selkirk(Executive Officer)in
Co-investorsKern Capital, LLCShearwater Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.